Literature DB >> 17920284

Intrastriatal inhibition of aromatic amino acid decarboxylase prevents l-DOPA-induced dyskinesia: a bilateral reverse in vivo microdialysis study in 6-hydroxydopamine lesioned rats.

Kerstin Buck1, Boris Ferger.   

Abstract

l-3,4-dihydroxyphenylalanine (l-DOPA)-induced dyskinesia consists of involuntary choreiform and dystonic movements. Here we report whether intrastriatal l-DOPA itself is able to trigger dyskinetic behavior and which role the neurotransmitter dopamine (DA) and its metabolites play. Intrastriatal l-DOPA as well as DA administration at the 6-hydroxydopamine (6-OHDA) lesioned side led to a significant appearance of dyskinetic behavior, whereas DA metabolites were ineffective. Intrastriatal inhibition of the enzyme aromatic amino acid decarboxylase (AADC) by benserazide prevented the appearance of l-DOPA-induced dyskinetic movements at the lesioned side. Principle component analysis of DA and DA metabolite levels with dyskinesia scores after l-DOPA/benserazide (6/15 mg/kg) administration indicated a significant correlation only for DA, whereas DA metabolites did not show any significant correlation with the occurrence of dyskinetic behavior. We conclude that intrastriatal l-DOPA itself is not able to induce dyskinetic movements, whereas the increase of intrastriatal DA levels is instrumental for l-DOPA- and DA-induced dyskinetic behavior.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17920284     DOI: 10.1016/j.nbd.2007.08.010

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  9 in total

1.  Are cyclooxygenase-2 and nitric oxide involved in the dyskinesia of Parkinson's disease induced by L-DOPA?

Authors:  Mariza Bortolanza; Fernando E Padovan-Neto; Roberta Cavalcanti-Kiwiatkoski; Maurício Dos Santos-Pereira; Miso Mitkovski; Rita Raisman-Vozari; Elaine Del-Bel
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-07-05       Impact factor: 6.237

2.  Flibanserin, a drug intended for treatment of hypoactive sexual desire disorder in pre-menopausal women, affects spontaneous motor activity and brain neurochemistry in female rats.

Authors:  Boris Ferger; Makoto Shimasaki; Angelo Ceci; Carina Ittrich; Kelly A Allers; Bernd Sommer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-04-27       Impact factor: 3.000

3.  Low dietary protein content alleviates motor symptoms in mice with mutant dynactin/dynein-mediated neurodegeneration.

Authors:  Diana Wiesner; Jérome Sinniger; Alexandre Henriques; Stéphane Dieterlé; Hans-Peter Müller; Volker Rasche; Boris Ferger; Sylvie Dirrig-Grosch; Rana Soylu-Kucharz; Asa Petersén; Paul Walther; Birgit Linkus; Jan Kassubek; Philip C Wong; Albert C Ludolph; Luc Dupuis
Journal:  Hum Mol Genet       Date:  2014-12-30       Impact factor: 6.150

4.  Dopamine release from serotonergic nerve fibers is reduced in L-DOPA-induced dyskinesia.

Authors:  Nina Nevalainen; Sara Af Bjerkén; Martin Lundblad; Greg A Gerhardt; Ingrid Strömberg
Journal:  J Neurochem       Date:  2011-05-25       Impact factor: 5.372

5.  L-Dihydroxyphenylalanine modulates the steady-state expression of mouse striatal tyrosine hydroxylase, aromatic L-amino acid decarboxylase, dopamine and its metabolites in an MPTP mouse model of Parkinson's disease.

Authors:  Jennifer M King; Gladson Muthian; Veronica Mackey; Marquitta Smith; Clivel Charlton
Journal:  Life Sci       Date:  2011-08-18       Impact factor: 5.037

6.  Exogenous corticosterone reduces L-DOPA-induced dyskinesia in the hemi-parkinsonian rat: role for interleukin-1beta.

Authors:  C J Barnum; K L Eskow; K Dupre; P Blandino; T Deak; C Bishop
Journal:  Neuroscience       Date:  2008-07-12       Impact factor: 3.590

7.  Cross-hemispheric dopamine projections have functional significance.

Authors:  Megan E Fox; Maria A Mikhailova; Caroline E Bass; Pavel Takmakov; Raul R Gainetdinov; Evgeny A Budygin; R Mark Wightman
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-13       Impact factor: 11.205

8.  Neurochemical changes in the striatum of dyskinetic rats after administration of the cannabinoid agonist WIN55,212-2.

Authors:  M G Morgese; T Cassano; S Gaetani; T Macheda; L Laconca; P Dipasquale; L Ferraro; T Antonelli; V Cuomo; A Giuffrida
Journal:  Neurochem Int       Date:  2008-11-01       Impact factor: 3.921

9.  L-dopa-induced dyskinesia: beyond an excessive dopamine tone in the striatum.

Authors:  Gregory Porras; Philippe De Deurwaerdere; Qin Li; Matteo Marti; Rudolf Morgenstern; Reinhard Sohr; Erwan Bezard; Michele Morari; Wassilios G Meissner
Journal:  Sci Rep       Date:  2014-01-16       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.